Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention: Phase 2b

NCT05352061 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT05352061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05352061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addressing Psychosocial Comorbidities in HIV Treatment and Prevention: Phase 2b
Lead sponsor
University of Miami
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 15, 2022
Completion date
May 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medication adherence, mental health issue